Home / News /

News

11.01.2016 Interview of Dr. N. Bovin, Scientific Director of LLC Semiotik to the editor of the special project of RBC magazine.
Interview of Dr. N. Bovin, Scientific Director of LLC Semiotik to the editor of the special project of RBC magazine.

22.09.2015 A group of researchers from LLC Semiotik headed by General Director took part in a seminar in Bulgaria under support of the fund EEA Grants.
A group of researchers from LLC Semiotik headed by General Director took part in a seminar in Bulgaria under support of the fund EEA Grants.

15.09.2015 Specialists of the Scientific Division of LLC Semiotik took part in Glyco 23 (23rd International Symposium on Glycoconjugates), Split, Croatia held on October 15-19, 2015.
Specialists of the Scientific Division of LLC Semiotik took part in Glyco 23 (23rd International Symposium on Glycoconjugates), Split, Croatia held on October 15-19, 2015.

12.05.2015 Semiotik LLC and GlycoTech Corporation (USA) concluded an agreement on distribution
Semiotik LLC and GlycoTech Corporation (USA) concluded an agreement on distribution of the product of LLC Semiotik, a research microchip for quantification of glycan-binding proteins,in North America. Detection of glycan-specific antibodies in blood opens the way to diagnostics of a wide range of infectious, autoimmune and oncological diseases. Mapping of specificity of bacterial and viral lectins and phage glycanases is the key stage in development of antimicrobial drug products of new generation,which are an alternative to classic antibiotics.
GlycoTech Corporation (USA) was founded in 1991; company is the key supplier of reagents for glycobiological studies in USA. The company performs active in-house studies in the field of the search of new glycotherapeutics and works as a partner for pharmaceutical companies and centers in the USA.

06.05.2015 Semiotik has delivered a first batch of glycochips to Yashraj Biotechnology Ltd in India
Semiotik has delivered a first batch of glycochips to Yashraj Biotechnology Ltd  in India (www.yashraj.com); this company has developed monoclonal antibodies specific to human tumor tissues. Testing results received with the help of microchips show that two out of seven antibodies are specifically bound to glycoligands. The data received opensa perspective for development of new antibodies targeted to both diagnostics and therapy in oncology.

21.10.2014 Interview with General Director of LLC Semiotik N.V. Bovin.

Weekly information and analysis edition Pharmaceutical Bulletin (Farmatsevticheskij Vestnik) published in section Innovators an interview with General Director of LLC Semiotik N.V. Bovin.

18.06.2014 III Partner Conference of RVC finishes in Moscow

Within the scope of the event more than 20 start-ups present their projects to the visitors. Project Semiotik, BioEc and MaxTelCom were the winners of the presentation competition.

16.06.2014 Microchips for blood analysis ‘Semiotik’ received the second investment tranche

Portfolio investment fund RVC – RVC Biofund in partnership with IC Russ-Invest decided to continue funding of the company and issued the second investment tranche to Semiotik, a company specialized in development and production of unique microchips for analysis of blood and donor plasma. Total sum of the tranche is 144 mln. roubles.

07.11.2013 Microchips for blood analysis ‘Semiotik’ raised investment

Portfolio investment fund RVC – RVC Biofund in partnership with IC Russ-invest made investment in company Semiotik. Investments of the partners will be put in finishing of the development of unique microchips for analysis of blood and donor plasma, clinical trials, and production start.

30.10.2013 Participant of Innovation Center Skolkovo

LLC Semiotik is granted a status of a Participant of Innovation Center Skolkovo

01.10.2013 Production of microchips

LLC Semiotik started the Project ‘Production of microchips for detection of specific immunoglobulins in blood’.